arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BIO KEY INTERNATIONAL INC

BKYI
$4.07 ▼ -0.01 (-0.25%) at close
Technology ·Services-Prepackaged Software ·USServices-Prepackaged Software
66 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
11
Health
Poor
Bearish
auto_awesome

Analytical Summary

BIO KEY INTERNATIONAL INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.2M
Dividend Yield
Revenue Growth 33.5%
Op. Margin -7.4%
ROIC -3.2%
FCF / Share $-0.35
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.15M
↑ +33.5%
Net Income Profit after all expenses
$-205.04K
↑ +72.2%
Operating Margin Operating profit as % of sales
-7.4%
↑ +87.2% 2th
FCF / Share Free cash flow per share
$-0.35
↓ -93.6%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
6
Financial Health
13
Cash Quality
46

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters